Portal de Periódicos da CAPES

Further experiences with Δ1, 9 alpha fluoro, 16 alpha hydroxyhydrocortisone (triamcinolone) in treatment of patients with rheumatoid arthritis

1958; Wiley; Volume: 1; Issue: 3 Linguagem: Inglês

10.1002/art.1780010304

1529-0131

R. H. Freyberg, Carl A. Berntsen, LEON HELLMAN,

Systemic Lupus Erythematosus Research

Abstract Cumulative observations concerning the use of triamcinolone in 74 patients with rheumatoid arthritis and in 15 with related rheumatic syndromes are reported. Anti‐inflammatory properties of this steroid were confirmed. Although disturbances in electrolyte metabolism were not observed, the usual undesirable effects resulting from the administration of glucocorticoids were noted. Es reportate observationes cumulative in re le uso de triamcinolona in 74 patientes con arthritis rheumatoide e in 15 patientes con syndromes rheumatic affin. Le qualitate anti‐inflammatori de iste steroide esseva confirmate. Ben que disturbationes in le metabolismo electrolytic non esseva observate, le usual effectos adverse que resulta del administration de glucocorticoides esseva observate.